Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis

Figure 6

Moderate immunoexpression of CD133 in patients with pancreatic cancer (magn. 200x).